Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Haider

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Biomaterials|January 11, 2011
Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repairLei Ye, Wei Zhang, Li-Ping Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancerR Jakesz, H Hausmaninger, K Haider, et al.
Onkologie|May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patientsF Ploner, R Jakesz, H Hausmaninger, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Biomaterials|January 11, 2011
Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repairLei Ye, Wei Zhang, Li-Ping Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancerR Jakesz, H Hausmaninger, K Haider, et al.
Onkologie|May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patientsF Ploner, R Jakesz, H Hausmaninger, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Pageof 9